Trial Profile
The Effect Of Fluvastatin XL Treatment On The Lipid Profile In Patients With Metabolic Syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2011
Price :
$35
*
At a glance
- Drugs Fluvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Novartis
- 14 Aug 2009 Actual patient number (614) added as reported by ClinicalTrials.gov.
- 14 May 2008 New trial record.